申联生物：股票交易异常波动公告

Core Viewpoint - The stock of Shenlian Bio has experienced an abnormal fluctuation, with a cumulative closing price increase of over 30% over three consecutive trading days, prompting the company to issue a statement confirming no undisclosed significant events [1]. Group 1 - Shenlian Bio's stock price increased significantly, with a cumulative rise of over 30% on August 14, 15, and 18, 2025 [1]. - The company conducted a self-examination and confirmed with its controlling shareholder and actual controller that there are no undisclosed significant matters as of the announcement date [1]. - The company's production and operations are normal, with no significant changes reported [1].